Browsing by Author Christou, L.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 1 to 20 of 51  next >
TitleAuthor(s)Issue date
Acute Haemophilus parainfluenzae endocarditis: a case reportChristou, L.; Economou, G.; Zikou, A. K.; Saplaoura, K.; Argyropoulou, M. I.; Tsianos, E. V.24-Nov-2015
Administration of a modified chemotherapeutic regimen containing vincristine, liposomal doxorubicin and dexamethasone to multiple myeloma patients: preliminary dataTsiara, S. N.; Kapsali, E.; Christou, L.; Panteli, A.; Pritsivelis, N.; Bourantas, K. L.24-Nov-2015
Antiplatelet antibodies in patients with chronic viral hepatitis receiving interferon-alphaChristodoulou, D.; Christou, L.; Zervou, E.; Katsanos, K.; Kitsanou, M.; Tsianos, E. V.24-Nov-2015
Association of liver cirrhosis related IgA nephropathy with portal hypertensionKalambokis, G.; Christou, L.; Stefanou, D.; Arkoumani, E.; Tsianos, E. V.24-Nov-2015
Bacterial infection-related morbidity and mortality in cirrhosisChristou, L.; Pappas, G.; Falagas, M. E.24-Nov-2015
Baseline cholesterol is associated with the response to antiviral therapy in chronic hepatitis CEconomou, M.; Milionis, H.; Filis, S.; Baltayiannis, G.; Christou, L.; Elisaf, M. S.; Tsianos, E.24-Nov-2015
Brucella as a biological weaponPappas, G.; Panagopoulou, P.; Christou, L.; Akritidis, N.24-Nov-2015
Category B potential bioterrorism agents: bacteria, viruses, toxins, and foodborne and waterborne pathogensPappas, G.; Panagopoulou, P.; Christou, L.; Akritidis, N.24-Nov-2015
Characteristics of ascitic fluid in cardiac ascitesChristou, L.; Economou, M.; Economou, G.; Kolettis, T. M.; Tsianos, E. V.24-Nov-2015
Chronic lupus ascitesAcritidis, N. C.; Christou, L.; Drosos, A. A.24-Nov-2015
Chronic myelogenous leukemia terminating in acute megakaryoblastic leukemia. Case reportBourantas, K. L.; Repousis, P.; Tsiara, S.; Christou, L.; Konstantinidou, P.; Bai, M.24-Nov-2015
Combination therapy with recombinant human erythropoietin, interferon-alpha-2b and granulocyte-macrophage colony-stimulating factor in idiopathic myelofibrosisBourantas, K. L.; Tsiara, S.; Christou, L.; Repousis, P.; Konstantinidou, P.; Bai, M.; Seferiadis, K.24-Nov-2015
Coxiella burnetii: an unusual ENT pathogenPappas, G.; Giannoutsos, C.; Christou, L.; Tsianos, E.24-Nov-2015
Cutaneous manifestations in brucellosis: case report and review of the literatureMilionis, H.; Christou, L.; Elisaf, M. S.24-Nov-2015
Cutaneous vasculitis as the initial manifestation in acute myelomonocytic leukemiaBourantas, K.; Malamou-Mitsi, V. D.; Christou, L.; Filippidou, S.; Drosos, A. A.24-Nov-2015
D-penicillamine induced myasthenia gravis: clinical, serological and genetic findingsDrosos, A. A.; Christou, L.; Galanopoulou, V.; Tzioufas, A. G.; Tsiakou, E. K.24-Nov-2015
Follow-up of 18 Patients with Chronic Myelomonocytic LeukemiaBourantas, K.; Christou, L.; Tsiara, S.; Galanakis, E.; Sirou, M.24-Nov-2015
Future trends in human brucellosis treatmentPappas, G.; Papadimitriou, P.; Christou, L.; Akritidis, N.24-Nov-2015
The global burden of bacterial and viral zoonotic infectionsChristou, L.24-Nov-2015
The globalization of leptospirosis: worldwide incidence trendsPappas, G.; Papadimitriou, P.; Siozopoulou, V.; Christou, L.; Akritidis, N.24-Nov-2015